Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-015405

Options or other derivatives

  • Chief Technical Officer acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shulman Joseph Chief Technical Officer 2026-02-11 Grant or award · Restricted Stock Units +15,000 15,000 D
Shulman Joseph Chief Technical Officer 2026-02-11 Grant or award · Stock Options (Right to Buy) +22,500 22,500 D
Loading xslF345X05/tm266366-7_4seq1.xml…